Tamoxifen enhances the cytotoxic effects of the nitrosourea fotemustine. Results on human melanoma cell lines
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (16) , 2269-2273
- https://doi.org/10.1016/0959-8049(93)90220-a
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursEuropean Journal Of Cancer, 1992
- Dermatologists Warn Nation of Increased Skin Cancer RiskJNCI Journal of the National Cancer Institute, 1992
- High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell linesBritish Journal of Cancer, 1992
- Treatment of Metastatic Malignant Melanoma with Dacarbazine plus TamoxifenNew England Journal of Medicine, 1992
- Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanomaAnnals of Oncology, 1991
- Reversal of acquired resistance to adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: role of drug interaction with alpha 1 acid glycoproteinBritish Journal of Cancer, 1990
- Tamoxifen metabolism: pharmacokinetic and in vitro studyBritish Journal of Cancer, 1989
- Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.Journal of Clinical Oncology, 1985
- ŒSTROGEN RECEPTORS IN HUMAN MALIGNANT MELANOMAThe Lancet, 1976
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949